Articles Open Access CC BY 4.0

The Use of NIHSS as an Assessment of Acute Stroke Severity

Yudhisman Imran , Ainaya Az Zahra
First published: 29 February 2024 |https://doi.org/10.47353/jsocmed.v3i2.128
PDF HTML XML

Abstract

Stroke is a neurological emergency that is characterized by sudden neurological deficits caused by vascular injury (infarction, hemorrhage) in the brain. In Indonesia, stroke is the main cause of disability and mortality. The mortality rate of stroke patients is closely related to the severity of the stroke experienced by the patient. Therefore, a scoring system is needed to assess the severity of acute stroke. The National Institutes of Health Stroke Scale (NIHSS) is used as the gold standard for assessing stroke severity. NIHSS also helps the treatment plan of stroke patients and determine the patient’s prognosis. The use of NIHSS in assessing the severity of acute stroke deserves further attention because it has a significant impact on the outcome of stroke patients during the treatment period.

Keywords: Stroke, Degree of severity, NIHSS

Downloads

Download data is not yet available.

INTRODUCTION

Stroke is a neurological emergency that occurs due to sudden disruption of blood flow to the brain. Stroke is classified into two based on its cause, namely ischemic stroke and hemorrhagic stroke. Ischemic stroke occurs when there is a blockage in the intracranial blood vessels resulting in disruption of blood flow to the brain.[1] In contrast, hemorrhagic stroke occurs when an intracranial blood vessel ruptures suddenly.[2] Stroke is the second highest cause of death worldwide.[3]

In Indonesia, stroke is the leading cause of disability and mortality. Along with increasing age, the incidence and prevalence of stroke continues to increase every year, especially in elderly patients.[4] The death rate of 356,183 or 21.12% due to stroke in Indonesia [5], making stroke one of the diseases that requires more attention in its management.[6]

Stroke is characterized by paralysis of the face or body on one side, slanted mouth, slurred or slurred speech, and can also be a sudden change in mental status.[7] These complaints can be assessed using a scoring system, namely the NIHSS. The National Institutes of Health Stroke Scale (NIHSS) is a scoring system used to assess the severity of acute stroke.[8] In addition to assessing severity, the NIHSS can be used to help plan stroke management and determine the patient's future prognosis. The use of NIHSS in the assessment of acute stroke severity is recommended as a valid scoring system and the most accessible worldwide.[9]

PATHOPHYSIOLOGY OF STROKE

The pathophysiology of stroke is based on the sudden disruption of blood flow to the brain. The clinical manifestations of stroke depend closely on the anatomy of the blood vessels that drain the brain. The presence of blockage or hemorrhage in intracranial blood vessels can cause focal or global neurologic deficits on the contralateral side of the lesion.[10]

Neurological deficits that can occur in patients are cranial nerve paresis, sensory disturbances, hemiparesis, aphasia, dysarthria, and inattention.[11] These symptoms will determine the severity of the stroke based on NIHSS scoring points. NIHSS examination is performed at least periodically every hour to prevent further damage or even death.[12]

RISK FACTORS

The incidence and prevalence of stroke are closely related to an individual's risk factors. Risk factors for stroke are broadly divided into non-modifiable and modifiable risk factors. Unmodifiable risk factors are fixed risk factors that cannot be changed through lifestyle improvements or medication. Examples are age, gender, race, and genetics (family history). Modifiable risk factors are risk factors of an individual that can be changed by improving lifestyle or through medication. Examples are conditions such as hypertension, diabetes mellitus, elevated cholesterol levels (dyslipidemia), smoking, obesity and inactivity. These risk factors can increase the severity of stroke and prolong the length of stay.[13]

According to a study conducted by Razdiq et al (2020), there is a relationship between systolic blood pressure (p=0.01) and diastolic blood pressure (p=0.004) with stroke severity through NIHSS examination.[14] In the study of Ayudia et al (2023) there was a relationship between Low-Density Lipoprotein (LDL) cholesterol levels and the length of stay of acute ischemic stroke patients (p=0.042). High LDL levels will increase the risk of atherosclerotic plaque formation.[15] Atherosclerosis is the main pathology causing ischemic stroke which is associated with endothelial dysfunction in blood vessels. Endothelial dysfunction in these vessels is assessed by measuring carotid artery tunica intima media thickness (CIMT) using Doppler ultrasonography (ultrasound).[16] Although no single stroke severity scoring system can predict overall recovery and disability after acute stroke, the NIHSS can be used as a reliable severity assessment due to the ease with which clinicians can use it.[17]

NATIONAL INSTITUTES OF HEALTH STROKE SCALE (NIHSS)

The National Institutes of Health Stroke Scale or NIHSS is a scoring system used to determine the severity of acute stroke.[8] The use of NIHSS is not limited to severity alone, the use of NIHSS in acute stroke cases helps to plan management and determine the patient's future prognosis.

Every clinician in the field of neurology, in determining prevention, assessment management in the acute phase, recovery, requires an assessment of severity, and the NIHSS has become the gold standard in determining the severity of acute stroke.[9] There are 15 assessment items that need to be considered in the use of NIHSS to determine the severity of acute stroke. The patient's NIHSS score is calculated by adding each score in the assessment items in the NIHSS sheet.[8]

The ability of the NIHSS to predict the patient's condition after a stroke helps the clinician to provide accurate information to the patient so as to set realistic goals for therapy and discharge planning.[8] The NIHSS assesses the patient's motor as well as non-motor weakness. This assessment yields a total score from 0 - 42, with a greater total score indicating greater stroke severity.[18]

THE USE OF NIHSS IN DETERMINING THE SEVERITY OF ACUTE STROKE

Stroke can cause neurological deficits that impair the patient's motor and non-motor abilities. Due to its progressivity, there is a need for an assessment tool that provides a quantitative measure of the severity of a patient's stroke as seen from the neurological deficits experienced.[19]

NIHSS as a systematic and standardized assessment tool helps clinicians to measure the level of neurological deficits of patients, while helping to identify which patients are suitable for fibrinolytic therapy, allowing clinicians to make objective measurements of changes in patients' clinical status, and identify patients at higher risk of complications such as intracerebral hemorrhage (ICH).[20]

The NIHSS examination includes the following: (1) Level of consciousness; (2) Eye movements; (3) Integrity of visual fields; (4) Facial movements; (5) Arm and leg muscle strength; (6) Sensation; (7) Coordination; (8) Language; (9) Speech; and (10) Neglect.[21]

CONCLUSION

Stroke is a neurological emergency that occurs due to sudden disruption of blood flow to the brain. Due to its progressivity, a systematic scoring system is required to assess the severity of a patient's stroke. The NIHSS makes it easy to quantify the extent of a patient's neurological deficit, allows clinicians to objectively measure changes in a patient's clinical status, and identifies patients at higher risk of complications. The NIHSS is also used in determining patient eligibility for appropriate therapy to improve neurological outcomes.

CONSENT FOR PUBLICATION

The Authors agree to publication in Journal of Society Medicine.

FUNDING

None

COMPETING INTERESTS

The authors declare that there is no conflict of interest.

AUTHORS’ CONTRIBUTIONS

All authors significantly contribute to the work this review, approved the final version to be published, agreed on the journal to be submitted, and agreed to be accountable for all aspects of the work.

ACKNOWLEDGMENTS

We would like to thank all those who have supported us during the writing process of this article.

REFERENCE

  1. Alegiani AC, Rahn AC, Steckelberg A, Thomalla G, Heesen C, Köpke S. Quality of Stroke Patient Information Applied in Randomized Controlled Trials: Literature Review. Frontiers in Neurology. 2020; 11: 1.
  2. Venketasubramanian N, Yudiarto FL, Tugasworo D. Stroke Burden and Stroke Services in Indonesia. Cerebrovasc Dis Extra. 2022;12(1).
  3. Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J. Harrison Principles of Internal Medicine. 20th edition. Vol. 1, McGraw-Hill Education. 2018.
  4. Unnithan AKA, Mehta P. Hemorrhagic Stroke - StatPearls - NCBI Bookshelf. In: Hemorrhagic Stroke. 2020.
  5. Saraswati, D R, Khariri. Transisi Epidemiologi Stroke Sebagai Penyebab Kematian Pada Semua Kelompok Usia Di Indonesia. J Kedokt. 2021; 2 (1): 1
  6. Kusuma Y, Venketasubramanian N, Kiemas LS, Misbach J. Burden of stroke in Indonesia. Int J Stroke. 2009; 4 (5): 1
  7. Murphy SJ, Werring DJ. Stroke: causes and clinical features. Vol. 48, Medicine (United Kingdom). 2020.
  8. Patrama AP, Tresno T, Purwanza SW. Development The National Institutes of Health Stroke Scale (NIHSS) for Predicting Disability and Functional Outcome to Support Discharge Planning After Ischemic Stroke. J Ners. 2020;14(3): 1
  9. Kwah LK, Diong J. National Institutes of Health Stroke Scale (NIHSS). J Physiother. 2014; 60 (1): 61.
  10. Kuriakose D, Xiao Z. Pathophysiology and treatment of stroke: Present status and future perspectives. Vol. 21, International Journal of Molecular Sciences. 2020.
  11. Lyden P. Using the National Institutes of Health Stroke Scale. Stroke. 2017; 48 (1): 1
  12. Damhudi D, Irawaty D, Hariyati RTS. Efektifitas Metode NIHSS dan ESS Dalam Membuat Diagnosa Keperawatan Aktual Pada Pasien Stroke Berat Fase Akut. J Keperawatan Indones. 2012; 15 (1): 7–12.
  13. Gofir A, Mulyono B, Sutarni SHyperglycemia as a prognosis predictor of length of stay and functional outcomes in patients with acute ischemic stroke, International Journal of Neuroscience. 2017: 127 (10): 1-17.
  14. Razdiq ZM, Imran Y. Hubungan antara tekanan darah dengan keparahan stroke menggunakan National Institute Health Stroke Scale. J Biomedika dan Kesehat. 2020; 3 (1): 15-20.
  15. Ayudia P, Imran Y. Kadar kolesterol LDL sebagai prediktor lama perawatan pada pasien stroke iskemik akut. Jurnal penelitian dan karya ilmiah Lembaga Penelitian Universitas Trisakti. 2023; 8 (2): 310-320.
  16. Rahmansyah M, Hairunisa N, Imran Y. et al Ketebalan Tunika Intima Media Karotis dan Fungsi Kognitif pada Wanita Menopause. Majalah Kedokteran Neuro Sains Perhimpunan Dokter Spesialis Saraf Indonesia. 2022; 39 (2): 91-94.
  17. Siniscalchi A. Use of stroke scales in clinical practice: Current concepts. Turkish J Emerg Med. 2022; 22 (3): 119–24.
  18. Steffen R, Hill DR, DuPont HL. Traveler’s diarrhea a clinical review. JAMA - Journal of the American Medical Association. 2015; 313 (1): 1
  19. Saudin D, Rajin M, Kesehatan FI, Pesantren U, Darul T, Jombang U. et al. Metode pengkajian neurologis menggunakan national institutes of health stroke scale pada pasien stroke di rsud dr iskak tulungagung. J EDUNursing. 2017;1(1):1–6.
  20. Warner JJ, Harrington RA, Sacco RL, Elkind MSV. Guidelines for the early management of patients with acute ischemic stroke 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke. 2019; 50 (1): 1
  21. Hoffman H. What is the NIH Stroke Scale (NIHSS)? Saebo. 2017.
  22. Kogan E, Twyman K, Heap J, Milentijevic D, Lin JH, Alberts M. Assessing stroke severity using electronic health record data: A machine learning approach. BMC Med Inform Decis Mak. 2020;20(1).
  23. Farooque U, Lohano AK, Kumar A, Karimi S, Yasmin F, Bollampally VC, et al. Validity of National Institutes of Health Stroke Scale for Severity of Stroke to Predict Mortality Among Patients Presenting With Symptoms of Stroke. Cureus. 2020; 1.
  24. Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Vol. 52, Stroke. 2021.
  25. Toyoda K, Koga M, Iguchi Y, Itabashi R, Inoue M, Okada Y, et al. Guidelines for intravenous thrombolysis (Recombinant tissue-type plasminogen activator), the third edition, march 2019: A guideline from the Japan stroke society. Neurol Med Chir (Tokyo). 2019;59 (12): 1
  26. Whiteley WN, Emberson J, Lees KR, Blackwell L, Albers G, Bluhmki E, et al. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis. Lancet Neurol. 2016;15 (9): 1
  27. Pratama LB, Amalia L, Juli C, Gamayani U, Hermawan AN. Clinical Outcome Of Stroke Patients Based On The National Institutes Of Health Stroke Scale (NIHSS) In A Tertiary Hospital. MNJ (Malang Neurol Journal). 2022; 9 (1): 17–23.
  28. Cheung CM, Tsoi TH, Hon SFK, Au-Yeung M, Shiu KL, Lee CN, et al. Using the National Institutes of Health Stroke Scale (NIHSS) to predict the mortality and outcome of patients with intracerebral haemorrhage. Hong Kong Med J. 2008; 14 (5): 1
  29. Claus JJ, Berghout BBP, Ikram MK, Wolters FJ. Validity of stroke severity assessment using medical records in a population-based cohort. J Stroke Cerebrovasc Dis. 2023; 32 (4): 1

Similar Articles

1 2 3 4 5 6 > >> 

You may also start an advanced similarity search for this article.